Oral Cavity Disease
6
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Prevalence and Clinical Implications of HPV Infection in Male IBD Patients
Comparison of Remimazolam and Propofol for Recovery of Ambulatory Upper Airway Surgery
RetracTOR/ Retractor for Image Guided Trans-Oral Surgery
Clinical Efficiency of Xanthan Hydrogels Containing Local Anesthetics Encapsulated in Nanostructured Lipid Carries
Microneedle Pretreatment as a Strategy to Improve the Effectiveness of Topical Anesthetics Formulations
Pain and Safety of Microneedles in Oral Cavity